To the annoyance of some shareholders, OrbusNeich Medical Group Holdings Limited (HKG:6929) shares are down a considerable 28% in the last month, which continues a horrid run for the company. The recent drop completes a disastrous twelve months for shareholders, who are sitting on a 70% loss during that time.
Although its price has dipped substantially, it's still not a stretch to say that OrbusNeich Medical Group Holdings' price-to-earnings (or "P/E") ratio of 8.4x right now seems quite "middle-of-the-road" compared to the market in Hong Kong, where the median P/E ratio is around 9x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/E.
With its earnings growth in positive territory compared to the declining earnings of most other companies, OrbusNeich Medical Group Holdings has been doing quite well of late. One possibility is that the P/E is moderate because investors think the company's earnings will be less resilient moving forward. If not, then existing shareholders have reason to be feeling optimistic about the future direction of the share price.
SEHK:6929 Price to Earnings Ratio vs Industry March 11th 2024 Keen to find out how analysts think OrbusNeich Medical Group Holdings' future stacks up against the industry? In that case, our free report is a great place to start.
Does Growth Match The P/E?
In order to justify its P/E ratio, OrbusNeich Medical Group Holdings would need to produce growth that's similar to the market.
Retrospectively, the last year delivered an exceptional 72% gain to the company's bottom line. Pleasingly, EPS has also lifted 344% in aggregate from three years ago, thanks to the last 12 months of growth. Therefore, it's fair to say the earnings growth recently has been superb for the company.
Turning to the outlook, the next three years should generate growth of 9.6% per year as estimated by the three analysts watching the company. Meanwhile, the rest of the market is forecast to expand by 15% per year, which is noticeably more attractive.
In light of this, it's curious that OrbusNeich Medical Group Holdings' P/E sits in line with the majority of other companies. It seems most investors are ignoring the fairly limited growth expectations and are willing to pay up for exposure to the stock. These shareholders may be setting themselves up for future disappointment if the P/E falls to levels more in line with the growth outlook.
The Bottom Line On OrbusNeich Medical Group Holdings' P/E
With its share price falling into a hole, the P/E for OrbusNeich Medical Group Holdings looks quite average now. Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.
We've established that OrbusNeich Medical Group Holdings currently trades on a higher than expected P/E since its forecast growth is lower than the wider market. Right now we are uncomfortable with the P/E as the predicted future earnings aren't likely to support a more positive sentiment for long. This places shareholders' investments at risk and potential investors in danger of paying an unnecessary premium.
The company's balance sheet is another key area for risk analysis. Take a look at our free balance sheet analysis for OrbusNeich Medical Group Holdings with six simple checks on some of these key factors.
Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a low P/E.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
いくつかの株主のいらだちにより、OrbusNeich Medical Group Holdings Limited (HKG:6929) の株価は先月にかなりの28%下落し、この会社にとってはひどい月の続きとなっています。最近の下落により、株主たちは惨憺たる12か月間を過ごし、その期間中に70%の損失を抱えています。
株価は大幅に下落しましたが、今現在のOrbusNeich Medical Group Holdingsの予想P/E比率は8.4倍で、香港市場の中央値である約9倍に比べてかなり「中間層」と言えます。ただし、このP/E比率に理性的な根拠がない場合、投資家たちは明確な機会や可能な不利益を見落としているかもしれません。
OrbusNeich Medical Group Holdingsは最近、他の企業の減少に対して収益成長がプラス圏であり、かなりうまくやっています。株式の方向性について楽観的な見通しを持っている株主が存在する理由の1つは、投資家たちが企業の収益が今後より少なくなると思っているため、P/E比率が中程度である可能性があることです。
SEHK:6929価格収益率と業種の比較2024年3月11日OrbusNeich Medical Group Holdingsの将来が業界と比べてどうなるか、アナリストたちの評価を知りたいですか?それなら、当社の無料レポートは最適な出発点となるでしょう。
成長がP/Eに合致するか?
OrbusNeich Medical Group Holdingsは、市場に類似した成長を生み出す必要があります。
このことから、OrbusNeich Medical Group HoldingsのP/Eが他の企業と同じであることが不思議です。かなり限定的な成長期待を無視し、株式への露出に高い価格を支払うことを望む投資家たちが多いようです。もしP/E比率が成長見通しにより一致するレベルまで下落すれば、これらの株主は将来の失望を招くことになるかもしれません。
OrbusNeich Medical Group HoldingsのP/Eについての最終的な見解
株価が暴落し、現在のOrbusNeich Medical Group HoldingsのP/E比率はかなり平均的になっています。株式を売却するために単独でP/E比率を使用することは賢明ではありませんが、これは会社の将来の可能性に対する実際的なガイドとなる可能性があります。
OrbusNeich Medical Group Holdingsが予測よりも成長見通しが低いため、現在は予想よりも高いP/E比率で取引されていることがわかりました。今後の収益予想が長くは続かないため、現在のP/E比率には不快感を覚えています。これは株主の投資をリスクにさらし、潜在的な投資家が不必要な超過利益を支払う危険性を伴います。
同社のバランスシートは、リスク分析の主要な領域の1つです。OrbusNeich Medical Group Holdingsの無料バランスシート分析を、これらの主要なファクターの6つの単純なチェックで調べてみてください。
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。